SGLT inhibitors (Jiangsu Hansoh Pharmaceutical)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameSGLT inhibitors (Jiangsu Hansoh Pharmaceutical)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium/glucose cotransporter 1 inhibitorsSodium/glucose cotransporter 2 inhibitors
TargetsSodium/glucose cotransporter 2Sodium/glucose cotransporter 1
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesJiangsu Hansoh Pharmaceutical Group Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJiangsu Hansoh Pharmaceutical Group Co Ltd
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A